Long-Term Outcomes With Nivolumab…h Advanced Melanoma.

🔬 Peer-reviewed

Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma.

Wolchok JD, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022